| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |